Friday, September 15, 2017 1:31:05 PM
From the Mayo Clinic:
"Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy.
Different factors, including genetics and some viruses, may contribute to type 1 diabetes. Although type 1 diabetes usually appears during childhood or adolescence, it can develop in adults.
Despite active research, type 1 diabetes has no cure. Treatment focuses on managing blood sugar levels with insulin, diet and lifestyle to prevent complications."
My point wasn't that Type I can be hereditary, it was that it isn't "Only hereditary" therefore this company is a scam.
"Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy.
Different factors, including genetics and some viruses, may contribute to type 1 diabetes. Although type 1 diabetes usually appears during childhood or adolescence, it can develop in adults.
Despite active research, type 1 diabetes has no cure. Treatment focuses on managing blood sugar levels with insulin, diet and lifestyle to prevent complications."
My point wasn't that Type I can be hereditary, it was that it isn't "Only hereditary" therefore this company is a scam.
Recent TXTM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 01:45:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:12:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:42 PM
- ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases • GlobeNewswire Inc. • 03/13/2026 03:29:44 PM
- Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement • GlobeNewswire Inc. • 01/20/2026 05:30:21 PM
- Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update • GlobeNewswire Inc. • 11/19/2025 06:05:51 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation • GlobeNewswire Inc. • 11/17/2025 07:41:34 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization — Ushering in a New Era of Transparency, Innovation, and Shareholder Confidence • GlobeNewswire Inc. • 11/07/2025 07:13:39 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation • GlobeNewswire Inc. • 10/31/2025 04:19:52 PM
- Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration • GlobeNewswire Inc. • 10/27/2025 05:21:34 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement • GlobeNewswire Inc. • 10/17/2025 01:43:14 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces New Member of Its Advisory Board • GlobeNewswire Inc. • 10/08/2025 03:58:18 PM
- ProText Mobility, Inc. Provides Shareholder Update • GlobeNewswire Inc. • 09/12/2025 01:44:35 PM
